How to Help Your Patients Find Cyclopentolate in Stock: A Provider's Guide

Your Patients Are Asking About Cyclopentolate — Here's How to Help

The ongoing Cyclopentolate shortage has created a ripple effect beyond your supply closet. Patients are hearing about the shortage, encountering empty pharmacy shelves, and coming to their appointments with questions and concerns. As a provider, you're in the best position to guide them — both in choosing the right approach for their care and in helping them navigate the practical challenge of finding medication when supply is limited.

This guide covers the current availability landscape, why patients are struggling to find Cyclopentolate, and five concrete steps you can take to help them get the care they need.

Current Availability

As of 2026, Cyclopentolate Hydrochloride ophthalmic solution remains on the FDA and ASHP drug shortage lists. Here's the supply picture:

• Alcon (Cyclogyl): Maintaining production of 0.5%, 1%, and 2% concentrations. Available through major distributors, though allocation limits may apply.
• Sandoz: Generic Cyclopentolate HCl available with intermittent stock levels.
• Bausch Health: Inconsistent supply; no public timeline for restoration.
• Akorn: Permanently discontinued all ophthalmic products following 2023 bankruptcy.
• Cyclomydril (combination): Also in shortage. Cyclopentolate 0.2%/Phenylephrine 1% combination drops have limited availability.

Compounding pharmacies have partially filled the gap. Pine Pharmaceuticals and others offer combination ophthalmic drops (such as TPC Drops) that include Cyclopentolate alongside Tropicamide and Phenylephrine.

Why Patients Can't Find Cyclopentolate

Understanding the patient's experience helps you provide better guidance. Here's what they're facing:

Retail Pharmacies Are Hit Hardest

While most Cyclopentolate is used in-office by providers, some patients do fill retail prescriptions — particularly those using Cyclopentolate at home for conditions like uveitis or for pre-exam preparation. These patients are the most directly affected by retail pharmacy shortages.

Chain Pharmacies Have Less Flexibility

Large chain pharmacies (CVS, Walgreens, Rite Aid) typically order from a single primary wholesaler. When that wholesaler is out of Cyclopentolate, the chain pharmacy has limited options. Independent pharmacies often work with multiple wholesalers and can source stock more creatively.

Patients Don't Know About Alternatives

Many patients don't realize that alternative medications exist. They hear "we don't have your eye drops" and assume their exam has to be postponed — when in reality, Tropicamide, Atropine, or a compounded combination product could work for their situation.

The Emotional Factor

For parents of children who need cycloplegic refraction, the shortage adds stress to an already anxiety-producing situation. Clear, proactive communication from your office can significantly reduce patient distress.

What Providers Can Do: 5 Steps

Step 1: Maintain a Diversified Supply Chain

Don't rely on a single distributor. Work with at least two to three wholesalers for your ophthalmic supplies. Consider establishing accounts with:

• Your primary medical distributor
• A secondary distributor or buying group
• An ophthalmic compounding pharmacy for emergency backup

Order Cyclopentolate 2 to 4 weeks in advance rather than waiting until you're nearly out. During the shortage, just-in-time ordering is a recipe for disruptions.

Step 2: Develop a Substitution Protocol

Have a documented clinical protocol for when Cyclopentolate isn't available. This saves time and ensures consistency across your team. A sample protocol:

• Routine adult refraction: Tropicamide 1% (1-2 drops, repeat in 5 min if needed)
• Routine pediatric refraction (non-strabismic): Tropicamide 1% (adequate for most cases per recent evidence)
• Suspected accommodative esotropia / high hyperopia: Atropine 1% (instilled at home 1-3 days prior to exam) OR reserve Cyclopentolate stock for these cases
• Fundus exam only (no cycloplegia needed): Tropicamide 0.5% + Phenylephrine 2.5%

Train your technicians and staff on the protocol so the workflow adapts smoothly when supply changes.

Step 3: Communicate Proactively With Patients

Don't wait for patients to ask. Address the shortage head-on:

• Add a note to appointment confirmation messages: "We may use an alternative dilating drop for your exam. This is safe and effective."
• Train front desk staff to explain, simply: "We're using a different but equally effective eye drop for dilation today due to a nationwide supply issue."
• For parents: Provide a brief written explanation of why a different drop is being used and what to expect afterward (especially regarding duration of effects).

Step 4: Direct Patients to Availability Tools

When patients do need a retail prescription for Cyclopentolate, direct them to resources that can help:

• Medfinder for Providers: Check pharmacy-level stock for Cyclopentolate and alternatives. Share the link with patients or look it up together during the appointment.
• Discount cards: For uninsured patients, remind them that GoodRx or SingleCare coupons can reduce the cost of generic Cyclopentolate from ~$30 to as low as $9-$12.
• Independent pharmacies: Recommend that patients try independent pharmacies, which may have access to stock through alternative distribution channels.

Step 5: Conserve Your Supply Strategically

When your Cyclopentolate stock is limited, use it where it matters most:

• Reserve Cyclopentolate for pediatric patients with strabismus, suspected high hyperopia, or accommodative esotropia.
• Use Tropicamide for routine adult and non-complex pediatric refractions.
• Use Phenylephrine as an adjunct for dilation-only exams where cycloplegia isn't required.
• Track your usage patterns to anticipate when you'll need to reorder.

Alternatives at a Glance

Quick reference for discussing substitutions with patients and staff:

• Tropicamide: Shorter-acting (4-8 hrs), weaker cycloplegia. Best for routine exams. Widely available.
• Atropine: Longest-acting (7-14 days), strongest cycloplegia. Best for complex pediatric cases. Requires advance preparation.
• Homatropine: Medium-acting (1-3 days). Less commonly used, but available for uveitis management.
• Phenylephrine: Mydriatic only — no cycloplegia. Use as adjunct for dilation.
• Compounded combinations: TPC Drops (Tropicamide + Phenylephrine + Cyclopentolate) available from specialty compounders.

For a full clinical comparison, see our provider briefing on the Cyclopentolate shortage for providers.

Workflow Tips

• Flag charts: Note which patients specifically require Cyclopentolate (vs. those who can receive Tropicamide) so your team can plan supply use ahead of the appointment day.
• Batch pediatric exams: If your Cyclopentolate supply is limited, consider scheduling complex pediatric refractions on specific days to optimize use of your remaining stock.
• Monitor ASHP and FDA databases weekly: Assign a staff member to check shortage status each week and report any changes.
• Document substitutions: Note in the patient chart which agent was used and why, especially if switching from the provider's typical protocol. This ensures continuity of care at follow-up visits.

Final Thoughts

The Cyclopentolate shortage is an operational challenge, but it doesn't have to compromise patient care. With a solid substitution protocol, diversified supply sources, proactive patient communication, and tools like Medfinder for Providers, your practice can navigate the shortage effectively.

The patients who need the most help are the ones filling retail prescriptions — arm them with information about where to look and how to save. For everything else, your clinical expertise and flexible workflow will carry the day.

Additional resources:

• How to help patients save money on Cyclopentolate
• Cyclopentolate drug interactions: What to avoid
• What is Cyclopentolate? Uses, dosage, and more